51
Participants
Start Date
February 6, 2017
Primary Completion Date
January 31, 2023
Study Completion Date
January 31, 2023
N-acetylcysteine
N-acetylcysteine is a safe, widely available supplement currently FDA-approved for treatment of acetaminophen antidote and as a mucolytic. It has effects on glutamate in the brain via the NMDA receptor as well as the glutathione antioxidant system (it is a precursor to glutathione).
Treatment as Usual
Treatment for schizophrenia which may include medications, therapy, or other types of treatment as determined by the subject's VA or community psychiatrist or mental health treatment team
UCLA Semel Institute for Neuroscience and Human Behavior, Los Angeles
University of California, Los Angeles
OTHER